Form 8-K - Current report:
SEC Accession No. 0001104659-25-025338
Filing Date
2025-03-19
Accepted
2025-03-19 07:08:55
Documents
55
Period of Report
2025-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259476d1_8k.htm   iXBRL 8-K 28863
2 EXHIBIT 99.1 tm259476d1_ex99-1.htm EX-99.1 14541
3 EXHIBIT 99.2 tm259476d1_ex99-2.htm EX-99.2 49800
7 GRAPHIC tm259476d1_001.jpg GRAPHIC 21351
8 GRAPHIC tm259476d1_002.jpg GRAPHIC 20696
9 GRAPHIC tm259476d1_ex99-2img001.jpg GRAPHIC 150721
10 GRAPHIC tm259476d1_ex99-2img002.jpg GRAPHIC 401801
11 GRAPHIC tm259476d1_ex99-2img003.jpg GRAPHIC 165545
12 GRAPHIC tm259476d1_ex99-2img004.jpg GRAPHIC 166089
13 GRAPHIC tm259476d1_ex99-2img005.jpg GRAPHIC 163225
14 GRAPHIC tm259476d1_ex99-2img006.jpg GRAPHIC 125615
15 GRAPHIC tm259476d1_ex99-2img007.jpg GRAPHIC 169706
16 GRAPHIC tm259476d1_ex99-2img008.jpg GRAPHIC 204589
17 GRAPHIC tm259476d1_ex99-2img009.jpg GRAPHIC 210925
18 GRAPHIC tm259476d1_ex99-2img010.jpg GRAPHIC 157865
19 GRAPHIC tm259476d1_ex99-2img011.jpg GRAPHIC 226613
20 GRAPHIC tm259476d1_ex99-2img012.jpg GRAPHIC 190515
21 GRAPHIC tm259476d1_ex99-2img013.jpg GRAPHIC 149152
22 GRAPHIC tm259476d1_ex99-2img014.jpg GRAPHIC 191116
23 GRAPHIC tm259476d1_ex99-2img015.jpg GRAPHIC 211215
24 GRAPHIC tm259476d1_ex99-2img016.jpg GRAPHIC 155546
25 GRAPHIC tm259476d1_ex99-2img017.jpg GRAPHIC 140566
26 GRAPHIC tm259476d1_ex99-2img018.jpg GRAPHIC 131535
27 GRAPHIC tm259476d1_ex99-2img019.jpg GRAPHIC 127302
28 GRAPHIC tm259476d1_ex99-2img020.jpg GRAPHIC 115547
29 GRAPHIC tm259476d1_ex99-2img021.jpg GRAPHIC 219889
30 GRAPHIC tm259476d1_ex99-2img022.jpg GRAPHIC 208133
31 GRAPHIC tm259476d1_ex99-2img023.jpg GRAPHIC 184712
32 GRAPHIC tm259476d1_ex99-2img024.jpg GRAPHIC 150404
33 GRAPHIC tm259476d1_ex99-2img025.jpg GRAPHIC 226380
34 GRAPHIC tm259476d1_ex99-2img026.jpg GRAPHIC 167386
35 GRAPHIC tm259476d1_ex99-2img027.jpg GRAPHIC 139320
36 GRAPHIC tm259476d1_ex99-2img028.jpg GRAPHIC 141911
37 GRAPHIC tm259476d1_ex99-2img029.jpg GRAPHIC 122883
38 GRAPHIC tm259476d1_ex99-2img030.jpg GRAPHIC 190813
39 GRAPHIC tm259476d1_ex99-2img031.jpg GRAPHIC 186967
40 GRAPHIC tm259476d1_ex99-2img032.jpg GRAPHIC 177783
41 GRAPHIC tm259476d1_ex99-2img033.jpg GRAPHIC 186711
42 GRAPHIC tm259476d1_ex99-2img034.jpg GRAPHIC 182788
43 GRAPHIC tm259476d1_ex99-2img035.jpg GRAPHIC 196927
44 GRAPHIC tm259476d1_ex99-2img036.jpg GRAPHIC 146019
45 GRAPHIC tm259476d1_ex99-2img037.jpg GRAPHIC 129388
46 GRAPHIC tm259476d1_ex99-2img038.jpg GRAPHIC 155053
  Complete submission text file 0001104659-25-025338.txt   9541263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20250318.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20250318_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20250318_pre.xml EX-101.PRE 22391
57 EXTRACTED XBRL INSTANCE DOCUMENT tm259476d1_8k_htm.xml XML 3696
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 25750852
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)